United Capital Corp. acquired the 136,000-square foot facility occupied by West-Ward Pharmaceuticals Inc. in Eatontown, N.J.
GREAT NECK, New York, July 20, 2017… United Capital Corp. today announced it has acquired the 136,000-square foot facility occupied by West-Ward Pharmaceuticals Inc. located at 401 Industrial Way West, Eatontown, NJ. The Tenant is one of the top generic prescription medication providers in the US offering both oral, solid and injectable pharmaceuticals to a growing number of chain stores, wholesalers, distributors, health systems and government agencies.
The facility is set on eight (8) acres and is conveniently located in the heart of Monmouth County, New Jersey. The building includes 20,000 square feet of Class A office space, and air-conditioned warehouse with 28 ft. ceilings and seven (7) loading docks.
This transaction is reflective of United Capital Corp’s vision of owning quality assets in in the Tri-State area and major metro markets throughout the United States.
United Capital Corp. and its subsidiaries own and manage real estate and hotel properties and provide engineered products to industrial and automotive markets worldwide.
Certain statements in this press release and other statements made by the Company or its representatives that are not strictly historical facts are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 that should be considered as subject to the many risks and uncertainties that exist in the Company’s operations and business environment. The forward-looking statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause the actual results, performance and/or achievements of the Company to differ materially from any future results, performance or achievements, expressed or implied, by the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, and that in light of the significant uncertainties inherent in forward-looking statements, the inclusion of such statements should not be regarded as a representation by the Company or any other person that the objectives or plans of the Company will be achieved. The Company also assumes no obligation to publicly update or revise its forward-looking statements or to advise of changes in the assumptions and factors on which they are based.